IN BRIEF: Evgen Pharma Doses First Patient In Lead Candidate Trial
IN BRIEF: Evgen Pharma Doses First Patient In Lead Candidate Trial
Read moreMon, 13th Feb 2017 08:21
IN BRIEF: Evgen Pharma Doses First Patient In Lead Candidate Trial
Read more(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced on Monday that the first patient had now been enrolled and dosed in the 'STAR' trial of its 'SFX-01' treatment for acute respiratory infections.
Read moreIN BRIEF: Evgen Pharma About To Begin SFX-01 Trial Recruitment
Read more(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced on Friday that all necessary regulatory approvals had now been received for the 'STAR' trial of SFX-01 treatment for Acute Respiratory Infections.
Read moreShares In Evgen Pharma Rise On Approval For SFX-01 Trial
Read moreUK WINNERS & LOSERS SUMMARY: Barclays Lifts FTSE's Lenders
Read moreUK EXECUTIVE CHANGE SUMMARY: Carr's Names Pelham To Replace CEO Davies
Read moreUK TRADING UPDATE SUMMARY: Mortgage Advice Bureau Launches Later Life
Read more(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced the licensing of its sulforaphane stabilisation technology in a number of non-pharmaceutical applications to Juvenescence on Tuesday.
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read more(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced its participation in the recently-notified funding initiative for Covid-19 clinical trials by the medical research charity LifeArc on Wednesday.
Read moreEvgen Pharma Says SFX-01 To Be Evaluated In Covid-19 Trial
Read moreUK WINNERS & LOSERS SUMMARY: Bunzl Rises As It Sees Strong First Half
Read moreEvgen Pharma Loss Slightly Wider On Expenses And Compensation
Read more(Sharecast News) - Clinical-stage drug development company Evgen Pharma reported a slight widening of its post-tax loss in its final results on Monday, to £2.7m, from £2.6m in the prior year.
Read more